Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Lister

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|September 23, 2000
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosaP D Lister
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1995
Multiply-resistant pneumococcus: therapeutic problems in the management of serious infectionsP D Lister
The American Journal of Managed Care|September 8, 2000
Emerging resistance problems among respiratory tract pathogensP D Lister
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic modelP D Lister
Annals of the Rheumatic Diseases|October 1, 1980
Arthritis associated with leucocytoclastic angiitisP D Lister, P Hollingworth
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniaeP D Lister, C C Sanders
Antimicrobial Agents and Chemotherapy|April 1, 1995
Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in miceP D Lister, C C Sanders
Antimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C Sanders
The Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C Sanders
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactionsM Alexov, P D Lister, C C Sanders
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|September 23, 2000
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosaP D Lister
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1995
Multiply-resistant pneumococcus: therapeutic problems in the management of serious infectionsP D Lister
The American Journal of Managed Care|September 8, 2000
Emerging resistance problems among respiratory tract pathogensP D Lister
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2001
Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic modelP D Lister
Annals of the Rheumatic Diseases|October 1, 1980
Arthritis associated with leucocytoclastic angiitisP D Lister, P Hollingworth
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniaeP D Lister, C C Sanders
Antimicrobial Agents and Chemotherapy|April 1, 1995
Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in miceP D Lister, C C Sanders
Antimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C Sanders
The Journal of Antimicrobial Chemotherapy|June 5, 2001
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniaeP D Lister, C C Sanders
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactionsM Alexov, P D Lister, C C Sanders
Pageof 2